179 related articles for article (PubMed ID: 30278532)
1. Tangier disease may cause early onset of atherosclerotic cerebral infarction: A case report.
Liang Z; Li W; Yang S; Liu Z; Sun X; Gao X; Yu G
Medicine (Baltimore); 2018 Sep; 97(39):e12472. PubMed ID: 30278532
[TBL] [Abstract][Full Text] [Related]
2. ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1.
Lhermusier T; Severin S; Van Rothem J; Garcia C; Bertrand-Michel J; Le Faouder P; Hechler B; Broccardo C; Couvert P; Chimini G; Sié P; Payrastre B
J Thromb Haemost; 2016 Mar; 14(3):585-95. PubMed ID: 26749169
[TBL] [Abstract][Full Text] [Related]
3. Tangier disease four decades of research: a reflection of the importance of HDL.
Kolovou GD; Mikhailidis DP; Anagnostopoulou KK; Daskalopoulou SS; Cokkinos DV
Curr Med Chem; 2006; 13(7):771-82. PubMed ID: 16611066
[TBL] [Abstract][Full Text] [Related]
4. Tangier disease: epidemiology, pathophysiology, and management.
Puntoni M; Sbrana F; Bigazzi F; Sampietro T
Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
[TBL] [Abstract][Full Text] [Related]
5. A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
Maranghi M; Truglio G; Gallo A; Grieco E; Verrienti A; Montali A; Gallo P; Alesini F; Arca M; Lucarelli M
Biochem Biophys Res Commun; 2019 Jan; 508(2):487-493. PubMed ID: 30503498
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.
Huang W; Moriyama K; Koga T; Hua H; Ageta M; Kawabata S; Mawatari K; Imamura T; Eto T; Kawamura M; Teramoto T; Sasaki J
Biochim Biophys Acta; 2001 Jul; 1537(1):71-8. PubMed ID: 11476965
[TBL] [Abstract][Full Text] [Related]
7. Subfraction analysis of circulating lipoproteins in a patient with Tangier disease due to a novel ABCA1 mutation.
Murano T; Yamaguchi T; Tatsuno I; Suzuki M; Noike H; Takanami T; Yoshida T; Suzuki M; Hashimoto R; Maeno T; Terai K; Tokuyama W; Hiruta N; Schneider WJ; Bujo H
Clin Chim Acta; 2016 Jan; 452():167-72. PubMed ID: 26616730
[TBL] [Abstract][Full Text] [Related]
8. A case report of Tangier disease presents with acute sensorimotor polyneuropathy and its treatment approach.
Karabudak S; Güzel V; Güler B; Uyanık B; Gürsoy AE
J Clin Lipidol; 2024; 18(2):e285-e289. PubMed ID: 38172008
[TBL] [Abstract][Full Text] [Related]
9. Accelerated Atherogenicity in Tangier Disease.
Muratsu J; Koseki M; Masuda D; Yasuga Y; Tomoyama S; Ataka K; Yagi Y; Nakagawa A; Hamada H; Fujita S; Hattori H; Ohama T; Nishida M; Hiraoka H; Matsuzawa Y; Yamashita S
J Atheroscler Thromb; 2018 Oct; 25(10):1076-1085. PubMed ID: 29563393
[TBL] [Abstract][Full Text] [Related]
10. A case of premature and recurrent myocardial infarction associated with ABCA.1 gene mutation.
Subramaniam K; Babu LA; Shah N
J Postgrad Med; 2021; 67(1):29-32. PubMed ID: 33380594
[TBL] [Abstract][Full Text] [Related]
11. Recurrent lobar intracerebral hemorrhage in Tangier disease.
Feng W; Sidorov E; Smith K; Selim M
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):909.e5-6. PubMed ID: 22133743
[TBL] [Abstract][Full Text] [Related]
12. A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency.
Hooper AJ; Robertson K; Ng L; Kattampallil JS; Latchem D; Willsher PC; Thom J; Baker RI; Burnett JR
Clin Chim Acta; 2009 Nov; 409(1-2):136-9. PubMed ID: 19723515
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
14. [The role of transmembrane lipidtransporter molecules in the atherosclerotic process].
Harangi M; Köbling T; Paragh G
Orv Hetil; 2006 Feb; 147(6):251-7. PubMed ID: 16610615
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches to treating cardiovascular disease: lessons from Tangier disease.
Oram JF
Expert Opin Investig Drugs; 2001 Mar; 10(3):427-38. PubMed ID: 11227043
[TBL] [Abstract][Full Text] [Related]
16. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease).
Nofer JR; Herminghaus G; Brodde M; Morgenstern E; Rust S; Engel T; Seedorf U; Assmann G; Bluethmann H; Kehrel BE
J Biol Chem; 2004 Aug; 279(32):34032-7. PubMed ID: 15163665
[TBL] [Abstract][Full Text] [Related]
17. Tangier disease and ABCA1.
Oram JF
Biochim Biophys Acta; 2000 Dec; 1529(1-3):321-30. PubMed ID: 11111099
[TBL] [Abstract][Full Text] [Related]
18. Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 ( ABCA1) gene in Japanese patients with Tangier disease.
Guo Z; Inazu A; Yu W; Suzumura T; Okamoto M; Nohara A; Higashikata T; Sano R; Wakasugi K; Hayakawa T; Yoshida K; Suehiro T; Schmitz G; Mabuchi H
J Hum Genet; 2002; 47(6):325-9. PubMed ID: 12111381
[TBL] [Abstract][Full Text] [Related]
19. ABC transporters, atherosclerosis and inflammation.
Fitzgerald ML; Mujawar Z; Tamehiro N
Atherosclerosis; 2010 Aug; 211(2):361-70. PubMed ID: 20138281
[TBL] [Abstract][Full Text] [Related]
20. Reduced platelet count, but no major platelet function abnormalities, are associated with loss-of-function ATP-binding cassette-1 gene mutations.
Minuz P; Meneguzzi A; Femia EA; Fava C; Calabria S; Scavone M; Benati D; Poli G; Zancanaro C; Calandra S; Lucchi T; Cattaneo M
Clin Sci (Lond); 2017 Aug; 131(16):2095-2107. PubMed ID: 28634189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
